Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Get the latest updates from Press releases directly as they happen.
Follow now 477 followers
Last updated 2 days ago
2 days ago
GSK announces headline results from the FIRST-ENGOT-OV44 phase III trial.
6 days ago
Vocabria + Rekambys is the first and only complete long-acting regimen for...
5 days ago
Regulatory designation based on promising preliminary clinical data.
6 days ago
Designation based on data showing no evidence of disease in 100% of...
6 days ago
Positive opinion based on statistically significant and clinically meaningful progression-free and overall...
12 days ago
DREAMM-7 trial shows sustained overall survival benefit for Blenrep (belantamab mafodotin) combination...
13 days ago
Nucala could be the first approved biologic with monthly dosing for patients...
13 days ago
Regulatory submission supported by phase III head-to-head DREAMM-7 trial showing statistically significant...
17 days ago
Shingrix collaboration extended to 2034
18 days ago
Important steps to advance access to first single-dose malaria treatment
25 days ago
Formulation supports simplification of vaccination process against invasive meningococcal disease (IMD).
27 days ago
Regulatory submission supported by phase III head-to-head DREAMM-7 and DREAMM-8 trials showing...